Stock Updates

Morning Watch List: Quest Diagnostics Incorporated (NYSE: DGX)

Quest Diagnostics Incorporated (NYSE: DGX) is a large market cap stock with a market cap of 14.58 B. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 21.14, a forward P/E of 18.03 and EPS of 5. At a stock price of 105.65 (0.50%) it has a dividend yield of 1.70%.

EPS growth for the last five years have been 9.70%, more recently this last year it has grown by -7.10%. The next year growth is going to be about 5.47% and more long-term 7.87% after five years. EPS growth quarter over quarter is 64.20%. Sales growth for the past five years have been 0.30% and sales growth quarter over quarter is 1.90%.

For performance, Quest Diagnostics Incorporated the past week has seen a gain of -1.64%. For the last month performance for Quest Diagnostics Incorporated is 7.69%. While the last quarter is 11.37% and half year, 25.18%. Finally for the year, performance is 40.36%.

The 52-week high for Quest Diagnostics Incorporated, is at -2.37%, and for the 52-week low it comes to a value of 43.21%. The 20-day simple moving average is -0.51% and 16.55% for the 200-day simple moving average.

Volatility for the week is at 1.28%, and for the month it is 1.37%. Quest Diagnostics Incorporated, has a target price of 103.09.

In terms of debt, long term debt/equity is 0.8, and for total debt/equity Quest Diagnostics Incorporated has 0.81. The gross margin is 39.40%, while operating margin is 17.20%, the profit margin is 9.30%. The current ratio is 1.6 and the quick ratio is 1.5.

Insider ownership is at 0.40%, with instituitional ownership at 94.60%. Quest Diagnostics Incorporated has a payout ratio of 32.50%. With the total shares outstanding coming to 138.03. The shares float is 136.24, with the float short at 3.95%, with short ratio coming to 6.09.

In terms of returns, the return on assets see Quest Diagnostics Incorporated, get 6.90%, with its returns on investment at 10.10%. Return on equity is 15.20%. So will the investors see the target price of 103.09, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 Quest Diagnostics Incorporated (NYSE: DGX)

About the author

Tony Dabbs

Leave a Comment